There were 1,943 press releases posted in the last 24 hours and 440,641 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image